Latest Board Changes News

Prodigy Gold NL reported significant gold intercepts from its Tanami North Project, alongside environmental baseline studies and a new 3D structural collaboration with CSIRO, positioning the company for future mining development.

Invex Therapeutics reports promising new data from its collaboration with Tessara Therapeutics on Exenatide’s potential in Alzheimer’s disease, alongside significant board changes and a solid cash position at quarter’s end.

Miramar Resources has restructured its board, appointing Marion Bush as Managing Director and Jono Fisher as Non-Executive Chairman, aiming to drive growth and exploration success in Western Australia.

Kingfisher Mining has completed a strategic acquisition of 11 tenements in New South Wales and commenced drilling at the Copper Blow IOCG prospect, while advancing rare earth element exploration in Western Australia.

29Metals delivered a robust December quarter at its Golden Grove mine with strong copper and zinc production, while Capricorn Copper remains suspended pending critical regulatory approvals. The company is progressing key growth projects and board changes as it navigates liquidity and operational challenges.

29Metals reported a strong December quarter with increased copper and zinc production at Golden Grove, cost efficiencies, and steady progress on key projects, while Capricorn Copper remains suspended pending regulatory approvals.

Bellevue Gold Limited reported a strong December quarter with rising grades and record ore mined, alongside a strategic reduction in its hedge book ahead of schedule. The company also achieved net zero emissions at its flagship project, underscoring its operational and sustainability credentials.

AuKing Mining reports promising exploration results at Myoff Creek and steady progress at Koongie Park, while grappling with a failed Cloncurry acquisition and significant board changes.

Talonx Resources has secured shareholder approval for two high-grade gold project acquisitions and extinguished $4.7 million in legacy debt, while completing drilling at its Viking Gold Project with assay results due soon.

Argent BioPharma has signed a binding agreement to acquire AusCann’s 48% stake in CannPal, enhancing its clinical and intellectual property assets for CannEpil®. The deal includes an option for the Neuvis® drug-delivery platform and aligns with Argent’s U.S. dual-listing ambitions.

Augustus Minerals has addressed ASX concerns over its recent appointment and election of a new director, clarifying compliance with listing rules despite timing challenges.

Southern Cross Media Group has completed its acquisition of Seven West Media, issuing shares to Seven shareholders and announcing significant leadership and board changes.